Jie Zang

4PUBLICATIONS
22CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 01, 2026
The Prognostic Value of 68Ga-PSMA and 18F-FDG PET/CT in Metastatic Castration-Resistant Prostate Cancer Treated with 177Lu-EB-PSMA.

|May 26, 2026
Design, Preclinical Evaluation, and Clinical Translation of [68Ga]Ga/[177Lu]Lu-JH120061, A Novel Radiopharmaceutical Targeting CXCR4.

|Jan 06, 2026
Response to Comments on "Pretreatment [⁶⁸Ga]-PSMA-11 PET/CT to Predict the Response to Treatment With Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors in Patients With Metastatic Renal Cell Carcinoma".

Shao-Hao Chen, Xiao-Hui Wu, Qian-Ren-Shun Qiu

|Oct 13, 2025
Pretreatment [⁶⁸Ga]-PSMA-11 PET/CT to Predict the Response to Treatment With Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors in Patients With Metastatic Renal Cell Carcinoma.

Shao-Hao Chen, Xiao-Hui Wu, Qian-Ren-Shun Qiu

Pageof 1

Frequent Collaborators

3 joint publications

Shaohao Chen

3 joint publications

Weibing Miao

3 joint publications

Ning Xu

2 joint publications

Xiao-Hui Wu